Search

everythinglearnresearchcommunity

for

Search:↓

Topical JAK inhibitors may help treat some skin conditions but need more research.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Narrowband UVB treatment increases certain gene expressions in psoriasis skin and improves symptoms.

Narrowband Ultraviolet B treatment can significantly reduce anxiety in psoriasis patients, but it doesn't significantly affect depression.

A shampoo with cannabidiol can significantly reduce scalp inflammation and symptoms in people with mild to moderate psoriasis or seborrheic dermatitis.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Fungal skin infections significantly lower patients' quality of life.

Disease-specific tools better assess quality of life in alopecia areata patients.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

Dermoscopy helps diagnose unusual skin lesions like osteonevus of Nanta and can prevent misdiagnosis of serious conditions.

A new method helps isolate key hair components to study hair growth and loss.

We need better research to improve alopecia treatment and patient care.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

A man's gray hair got darker and thicker after using a psoriasis drug.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Adiponectin and bradykinin play important roles in skin health and may help treat skin conditions.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

People with pattern hair loss have higher polyamine levels in the top of their head compared to the back.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Specialized ribosomes affect aging in human skin cells.

The robotic system for hair restoration surgery works well, giving similar results to manual techniques after 9 months.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.